• Skip to Navigation
  • Skip to Content
MENU
URMC HOME
  • Telephone: 585-275-2877
UR Medicine UR Medicine

UR Medicine Cardiac Care

Cardiac Care

  • Cardiac Care Home
  • Telephone: 585-275-2877
  • Services
  • Locations
  • Team
  • Patient Stories
  • For Patients
  • For Providers
  • Make a Gift

Our Services

  • Specialty Programs
  • Treatments
  • Conditions
  • Diagnostic Tests
  • Specialty Programs
  • Treatments
  • Conditions
  • Diagnostic Tests

Cardio-Oncology Program

Cancer patients who receive chemotherapy as part of their treatment may be at increased risk for cardiotoxicity and vascular disease. New cancer therapies may interfere with normal cardiac function. Specialists trained in cardio-oncology can detect these adverse reactions at an early stage and develop personalized treatment plans to avoid serious cardiovascular complications.

UR Medicine Cardiac Care is collaborating with the Wilmot Cancer Institute to offer our unique Cardio-Oncology Program—the only one of its kind in Upstate New York.

We use innovative imaging techniques such as strain echocardiography, cardiac MRI, angiography, and associated endomyocardial biopsy to identify patients and address their risk factors to minimize potential cardiotoxicity. And, for those who have already developed cardiotoxicity, we’ll treat it.

Have questions about cancer therapy and heart damage?

Learn more about cancer therapy and its affect on the heart.

 

Cardiac Resynchronization Therapy Benefits Cancer Survivors with Heart Failure

Our team is working on new solutions for people who have heart damage from chemotherapy. In this nationwide study, a pacemaker-like device restored heart function in a group of cancer survivors. Researchers from URMC led the nationwide study, which was reported in the Journal of the American Medical Association.

Read More

Find out more today

If you or a loved one is a cancer patient receiving chemotherapy and you have concerns about cardiotoxicity, contact the UR Medicine Cardio-Oncology Program at (585) 275-2475.

For more information or to request an appointment

call us at

585-275-2475

Did You Know?

Today, there are nearly 25 chemotherapeutic agents that may be associated with heart dysfunction. Plus, when cancer patients develop chemotherapy cardiotoxicity, it may limit the ability of oncologists to use chemotherapy agents known to eradicate cancer and limit cancer's recurrence

When we use medications such as selective ACE-inhibitors, ARB's, beta blockers and aldosterone blockers to protect a patient's heart, they can continue receiving necessary chemotherapeutic agents while minimizing their risk for developing heart disease.

Medicine of the Highest Order

  • University of Rochester Medical Center
  • MyChart Portal
  • Newsroom
  • Jobs
  • Privacy Policy
  • Accessibility